Cargando…

Heart rate control with landiolol hydrochloride in infants with ventricular dysfunction and pulmonary hypertension

AIMS: Sinus tachycardia potentially leads to a deterioration of cardiac function in critically ill infants. The ultrashort‐acting beta‐blocker landiolol hydrochloride is a new pharmacological option for a selective heart rate (HR) control in patients with sinus tachycardia and heart failure. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schroeder, Lukas, Monno, Paulina, Unger, Martin, Ackerl, Jakob, Shatilova, Olga, Schmitt, Joachim, Dresbach, Till, Mueller, Andreas, Kipfmueller, Florian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871696/ https://www.ncbi.nlm.nih.gov/pubmed/36256500 http://dx.doi.org/10.1002/ehf2.14202

Ejemplares similares

Intravenous sildenafil for treatment of early pulmonary hypertension in preterm infants
por: Schroeder, Lukas, et al.
Publicado: (2023)

Evaluation of levosimendan as treatment option in a large case-series of preterm infants with cardiac dysfunction and pulmonary hypertension
por: Schroeder, Lukas, et al.
Publicado: (2023)

Feasibility of bedside portable MRI in neonates and children during ECLS
por: Sabir, Hemmen, et al.
Publicado: (2023)

Safety and Efficacy of Landiolol Hydrochloride in Children with Tachyarrhythmia of Various Etiologies
por: Ashida, Atsuko, et al.
Publicado: (2021)

Effect of Landiolol Hydrochloride on Hemodynamics in a Histamine-Induced Shock Model
por: Hirano, Masaharu, et al.
Publicado: (2021)

A case of ultrashort‐acting beta‐blocker landiolol hydrochloride for takotsubo syndrome with left ventricular outflow tract obstruction
por: Takama, Takuro, et al.
Publicado: (2018)

Target-controlled infusion and population pharmacokinetics of landiolol hydrochloride in patients with peripheral arterial disease
por: Kunisawa, Takayuki, et al.
Publicado: (2015)

Landiolol hydrochloride for prevention of atrial fibrillation during esophagectomy: a randomized controlled trial
por: Aoki, Yoshitaka, et al.
Publicado: (2020)

Evaluating the Therapeutic Efficacy and Safety of Landiolol Hydrochloride for Management of Arrhythmia in Critical Settings: Review of the Literature
por: Matsuishi, Yujiro, et al.
Publicado: (2020)

Circulating microRNAs are associated with Pulmonary Hypertension and Development of Chronic Lung Disease in Congenital Diaphragmatic Hernia
por: Herrera-Rivero, Marisol, et al.
Publicado: (2018)

CA125: a novel cardiac biomarker for infants with congenital diaphragmatic hernia
por: Schroeder, Lukas, et al.
Publicado: (2022)

Safety of Landiolol Hydrochloride as a Premedication for Producing an Appropriate Heart Rate for Multidetector-Row Computed Tomography Coronary Angiography
por: Koyoshi, Rie, et al.
Publicado: (2018)

Beta-Blocker Landiolol Hydrochloride in Preventing Atrial Fibrillation Following Cardiothoracic Surgery: A Systematic Review and Meta-Analysis
por: Hao, Jianqi, et al.
Publicado: (2021)

Perioperative Administration of an Intravenous Beta-Blocker Landiolol Hydrochloride in Patients with Lung Cancer: A Japanese Retrospective Exploratory Clinical Study
por: Sakamoto, Atsuhiro, et al.
Publicado: (2019)

Practical applicability of landiolol, an ultra-short-acting β1-selective blocker, for rapid atrial and ventricular tachyarrhythmias with left ventricular dysfunction
por: Wada, Yuko, et al.
Publicado: (2016)

Safety and effective use of landiolol in the ICU
por: Hifumi, Toru, et al.
Publicado: (2014)

Recurrent ventricular arrhythmia due to aconite intoxication successfully treated with landiolol: A case report
por: Matsuo, Chiaki, et al.
Publicado: (2023)

Landiolol for rate control management of atrial fibrillation in patients with cardiac dysfunction
por: von Haehling, Stephan, et al.
Publicado: (2018)

Study of hemodynamics in patients treated with landiolol in the ICU
por: Imabayashi, T, et al.
Publicado: (2009)

Landiolol for managing atrial fibrillation in intensive care
por: Rehberg, Sebastian, et al.
Publicado: (2018)

Landiolol for managing post-operative atrial fibrillation
por: Balik, Martin, et al.
Publicado: (2018)

Novel rate control strategy with landiolol in patients with cardiac dysfunction and atrial fibrillation
por: Imamura, Teruhiko, et al.
Publicado: (2020)

Landiolol for managing atrial fibrillation in post-cardiac surgery
por: Fellahi, Jean-Luc, et al.
Publicado: (2018)

Efficacy and Safety of Landiolol in Patients With Ventricular Tachyarrhythmias With or Without Renal Impairment　― Subanalysis of the J-Land II Study ―
por: Shiga, Tsuyoshi, et al.
Publicado: (2020)

Dose-Finding Study of Landiolol Hydrochloride: A Short-Acting β(1)-Blocker for Controlling Heart Rate During Coronary Computed-Tomography Angiography in Japan
por: Hirano, Masaharu, et al.
Publicado: (2013)

Landiolol for refractory tachyarrhythmias in the intensive care unit: case reports
por: Gangl, Clemens, et al.
Publicado: (2022)

The Effectiveness and Safety of Landiolol Hydrochloride, an Ultra-Short-Acting β(1)-Blocker, in Postoperative Patients with Supraventricular Tachyarrhythmias: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
por: Taenaka, Nobuyuki, et al.
Publicado: (2013)

Effect of landiolol on sex-related transcriptomic changes in the myocardium during sepsis
por: Tran, Thi Thom, et al.
Publicado: (2019)

Pharmacodynamic and pharmacokinetic behavior of landiolol during dobutamine challenge in healthy adults
por: Krumpl, Günther, et al.
Publicado: (2020)

Dynamics of pulmonary hypertension severity in the first 48 h in neonates with prenatally diagnosed congenital diaphragmatic hernia
por: Leyens, Judith, et al.
Publicado: (2023)

A randomized, double-blind, placebo-controlled, phase II dose-finding study of the short acting β(1)-blocker, landiolol hydrochloride, in patients with suspected ischemic cardiac disease
por: Jinzaki, Masahiro, et al.
Publicado: (2013)

Mid-Term Prognosis After Landiolol Treatment in Atrial Fibrillation/Atrial Flutter Patients With Chronic Heart Failure　― A Prospective Observational Survey (AF-CHF Landiolol Survey) ―
por: Yamashita, Takeshi, et al.
Publicado: (2020)

Landiolol reduces hemodynamic responses to bronchoscopy-assisted suctioning in intubated ICU patients
por: Tochikubo, Junpei, et al.
Publicado: (2014)

Landiolol: pharmacology and its use for rate control in atrial fibrillation in an emergency setting
por: Domanovits, Hans, et al.
Publicado: (2018)

Efficacy of Intravenous Administration of Landiolol in Patients With Acute Heart Failure and Supraventricular Tachyarrhythmia
por: Kiuchi, Shunsuke, et al.
Publicado: (2017)

Role of Neutrophil CD64 Index as a Screening Marker for Late-Onset Sepsis in Very Low Birth Weight Infants
por: Kipfmueller, Florian, et al.
Publicado: (2015)

Preventive effect of low-dose landiolol on postoperative atrial fibrillation study (PELTA study)
por: Sasaki, Konosuke, et al.
Publicado: (2020)

Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial
por: Unger, Martin, et al.
Publicado: (2018)

Echocardiographic Assessment of Pulmonary Hypertension in Neonates with Congenital Diaphragmatic Hernia Using Pulmonary Artery Flow Characteristics
por: Kipfmueller, Florian, et al.
Publicado: (2022)

Impacts of Patient Characteristics on the Effectiveness of Landiolol in AF/AFL Patients Complicated with LV Dysfunction: Subgroup Analysis of the J-Land Study
por: Kinugawa, Koichiro, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4rurb1t2in1n0c79f9g9uioql4